MAPK9 and breast carcinoma: Although JNK1-deficiency and JNK2-deficiency did not suppress mammary carcinogenesis in the Trp53 BALB/c mouse model, we cannot exclude the possibility that deficiency of both JNK1 plus JNK2 might reduce the formation of mammary carcinoma.